Triple versus dual antiplatelet therapy for coronary heart disease patients undergoing percutaneous coronary intervention: A meta-analysis

Coronary heart disease (CHD) is the leading cause of mortality worldwide. Previous studies have suggested that cilostazol-based triple antiplatelet therapy (TAT) may be more effective than conventional dual antiplatelet therapy (DAT) at improving the clinical outcomes of patients with CHD undergoing...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHOU, HONG, FENG, XIAO-LING, ZHANG, HONG-YING, XU, FEI-FEI, ZHU, JIE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797250/
https://www.ncbi.nlm.nih.gov/pubmed/24137311
http://dx.doi.org/10.3892/etm.2013.1238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797250/
https://www.ncbi.nlm.nih.gov/pubmed/24137311
http://dx.doi.org/10.3892/etm.2013.1238

Ejemplares similares